Drug profile · INN
zilovertamab
zilovertamab is a inactive tyrosine-protein kinase transmembrane receptor ror1 inhibitor.
NMPA: clinical trials
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — zilovertamab
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 5
- Data quality
- 0.70
Quick answer
zilovertamab is a inactive tyrosine-protein kinase transmembrane receptor ror1 inhibitor.
Key facts
INN zilovertamab
Mechanism Inactive tyrosine-protein kinase transmembrane receptor ROR1 inhibitor
Target Inactive tyrosine-protein kinase transmembrane receptor ROR1
Mechanism of action
Inactive tyrosine-protein kinase transmembrane receptor ROR1 inhibitor
Primary target: Inactive tyrosine-protein kinase transmembrane receptor ROR1
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Pipeline programs
Frequently asked questions
What is zilovertamab?
zilovertamab is a inactive tyrosine-protein kinase transmembrane receptor ror1 inhibitor.